People increasingly turn to AI chatbots for health information, revealing gaps in healthcare access
A new study published in Nature Health examines how people are using AI chatbots to answer health and wellness questions, highlighting a trend of seeking medical information through artificial intelligence. This reflects broader challenges in healthcare accessibility and the quality of health information available online. The findings raise important questions about the responsibilities of AI companies in providing accurate health guidance and the adequacy of traditional healthcare provision.
Research presented in Nature Health documents how individuals are increasingly relying on AI-powered chatbots to address health-related questions, a phenomenon that mirrors the earlier trend of 'googling symptoms.' The study, led by Costa-Gomez and colleagues, systematically assesses health queries directed to generalist large language model chatbots. This shift toward AI for health information reflects existing gaps in healthcare accessibility and the challenges people face in obtaining reliable medical guidance through traditional channels. While AI chatbots offer convenient access to information, the quality and accuracy of their responses remain variable, similar to concerns about health information found through general internet searches. The research underscores the need for AI companies to take greater responsibility in ensuring their health-related outputs are accurate and appropriate, while also highlighting systemic issues in healthcare provision that drive people to seek alternative information sources.
What's missing
The article does not provide specific data on the accuracy rates of AI chatbot responses to health queries, nor does it discuss potential regulatory frameworks or guidelines that might govern AI use in healthcare contexts. Additionally, there is limited discussion of demographic variations in who relies on AI for health information or disparities in access to traditional healthcare that might drive this behavior.
How coverage differed
The Nature News article presents this as a neutral scientific observation about emerging behavior patterns and systemic healthcare gaps, citing peer-reviewed research. The framing emphasizes both opportunities and challenges without advocating for particular policy positions, though the author's competing interest in an AI healthcare startup could potentially influence perspective on AI's role in medicine.
What different sources said
- Nature NewsCenter
People are turning to AI chatbots to plug gaps in health information
Related
Study Finds Health Risks From One Alcoholic Drink Daily; Trump Administration Did Not Include Findings in New Dietary Guidelines
A government-commissioned study released independently found that consuming even one alcoholic drink per day increases health risks and that no level of alcohol has protective health effects. The research was originally intended to inform updated U.S. dietary guidelines but was not featured in the final 2025-2030 guidelines released by the Trump administration. The dispute highlights tensions between the scientific community and the current administration over how research influences public health policy.
FDA Approves Bemotrizinol, First New Sunscreen Ingredient in Over 25 Years
The FDA approved bemotrizinol, a new sunscreen ingredient that has been used in Europe since 1999, marking the first approval of a novel sunscreen ingredient in the U.S. in more than 25 years. The ingredient protects against both UVA and UVB rays without leaving white streaks like mineral-based sunscreens and will initially be sold under the brand name Parsol Shield by DSM Nutritional Products. The approval represents a significant update to American sunscreen technology and demonstrates the effectiveness of a streamlined approval process authorized by Congress in 2020.
Study Finds 2.8% of U.S. Population Used Psilocybin in Past Year
A nationally representative survey found that more than 8 million Americans, approximately 2.8% of the population, reported using psilocybin in the year prior to the survey. The data comes from the 2024 National Survey on Drug Use and Health, which surveyed 58,000 people age 12 and older. This finding provides updated prevalence data on psilocybin use as research into its therapeutic potential continues to expand.